Table 3.
Group 1 | Group 2 | Significance | |
---|---|---|---|
Age, y | 56.6 ± 2.2 | 60.9 ± 1.3 | NS |
SBP, mm Hg | 129.9 ± 3.4 | 136.5 ± 3.7 | NS |
DBP, mm Hg | 74.4 ± 1.9 | 76.4 ± 2.4 | NS |
LV function data | |||
LVEF% | 39.6 ± 1.9 | 39.9 ± 1.9 | NS |
LVEDD, mm | 61.9 ± 1.5 | 58.9 ± 1.4 | NS |
LVEDP, mm | 10.6 ± 1.4 | 15.1 ± 2.1 | NS |
LV mass index, g/m2 | 140.0 ± 6.8 | 149.3 ± 10.0 | NS |
BNP, pg/mL | 53.1 ± 12.9 | 163.9 ± 42.4 | NS |
Cardiovascular risk factors | |||
Total cholesterol, mg/dL | 202.4 ± 8.1 | 191.6 ± 9.7 | NS |
HDL cholesterol, mg/dL | 44.4 ± 2.1 | 50.1 ± 2.3 | P = .07 |
LDL cholesterol, mg/dL | 131.5 ± 8.1 | 119.5 ± 7.3 | NS |
Total to HDL cholesterol | 4.8 ± 0.24 | 3.9 ± 0.18 | P = .009 |
Plasma triglycerides, mg/dL | 118.8 ± 12.7 | 110.4 ± 18.1 | NS |
BMI, kg/m2 | 27.9 ± 0.69 | 25.9 ± 0.65 | P = .037 |
Glucose, mg/dL | 108.0 ± 6.1 | 109.0 ± 5.9 | NS |
HOMA index | 2.82 ± 0.27 | 2.61 ± 0.39 | NS |
Inflammatory markers | |||
IL-6, pg/mL | 1.2 ± 0.27 | 1.8 ± 0.45 | NS |
TNFα, pg/mL | 7.3 ± 0.19 | 7.4 ± 0.42 | NS |
CRP, mg/dL | 0.22 ± 0.052 | 0.52 ± 0.17 | NS |